Markets:

Overview

News

Currencies

International

Treasuries

Bicara Therapeutics Inc. - Common Stock (NQ:BCAX)

16.81 +1.33 (+8.59%)

Streaming Delayed Price Updated: 1:56 PM EST, Feb 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bicara Therapeutics Inc. - Common Stock

< Previous 1 2 Next >

Bicara Therapeutics to Participate in Upcoming Investor Conferences

Today 8:30 EST

From Bicara Therapeutics Inc.

Via GlobeNewswire

Ficerafusp Alfa 2000mg Q2W Demonstrates Deep, Durable Responses in 1L R/M HPV-Negative HNSCC and Supports Development of Less Frequent Dosing Regimen

February 19, 2026

From Bicara Therapeutics Inc.

Via GlobeNewswire

Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

February 05, 2026

From Bicara Therapeutics Inc.

Via GlobeNewswire

Bicara Therapeutics Announces Phase 3 Optimal Dose and Provides 2026 Corporate Outlook

January 12, 2026

From Bicara Therapeutics Inc.

Via GlobeNewswire

Bicara Therapeutics to Present at the J.P. Morgan 2026 Annual Healthcare Conference on Monday, January 12

December 15, 2025

From Bicara Therapeutics Inc.

Via GlobeNewswire

Bicara Therapeutics’ Preliminary Phase 1b Expansion Cohort Data Evaluating 750mg of Ficerafusp Alfa Weekly Plus Pembrolizumab Advances Pivotal Study Dose Selection on Track for First Quarter 2026

December 06, 2025

From Bicara Therapeutics Inc.

Via GlobeNewswire

Bicara Therapeutics Announces Publication of an Abstract with Preliminary Phase 1b Expansion Cohort Data Evaluating 750mg of Ficerafusp Alfa Weekly Plus Pembrolizumab in 1L HPV-negative R/M HNSCC at ESMO Asia 2025

December 01, 2025

From Bicara Therapeutics Inc.

Via GlobeNewswire

Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For

November 20, 2025

Via Investor Brand Network

Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For

November 20, 2025

From BioMedWire

Via GlobeNewswire

Bicara Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

November 10, 2025

From Bicara Therapeutics Inc.

Via GlobeNewswire

Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology

October 27, 2025

Via Investor Brand Network

Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology

October 27, 2025

EQNX::TICKER_START (OTCQB:OTLC),(NASDAQ:IOBT),(NYSE:NVS),(NASDAQ:BCAX),(NYSE:PFE) EQNX::TICKER_END

Via FinancialNewsMedia

These stocks that are showing activity before the opening bell on Monday. ↗

October 13, 2025

As we await the opening of the US market on Monday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

Via Chartmill

Bicara Therapeutics Announces Ficerafusp Alfa Granted Breakthrough Therapy Designation by U.S. FDA for 1L HPV-Negative R/M HNSCC

October 13, 2025

Designation supported by results from multiple dose cohorts from the Phase 1/1b trial of ficerafusp alfa in 1L HPV-negative R/M HNSCC

From Bicara Therapeutics Inc.

Via GlobeNewswire

4 Biotech Stocks Seeing Explosive Momentum Gains ↗

October 07, 2025

The SPDR S&P Biotech ETF (ARCA:XBI) is up more than 40% over the past six months and is on the verge of breaking out. Here's a look at several momentum standouts in the biotech space that appear to be...

Via Benzinga

Topics ETFs Stocks

Bicara Therapeutics to Participate in Upcoming Investor Conferences

August 27, 2025

From Bicara Therapeutics Inc.

Via GlobeNewswire

Bicara Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

August 12, 2025

From Bicara Therapeutics Inc.

Via GlobeNewswire

Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors

June 11, 2025

From Relay Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

June 04, 2025

Via Benzinga

Bicara Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

June 03, 2025

From Bicara Therapeutics Inc.

Via GlobeNewswire

Bicara Therapeutics Demonstrates Deep and Durable Responses with Ficerafusp Alfa Plus Pembrolizumab in 1L HPV-Negative R/M HNSCC at ASCO 2025

June 01, 2025

From Bicara Therapeutics Inc.

Via GlobeNewswire

Bicara Therapeutics Shares Sink Over 43% On Mixed Phase 1/1b Trial Results: What's Going On? ↗

May 23, 2025

Bicara Therapeutics Inc. (NASDAQ: BCAX) shares are trading lower Friday following the release of updated interim data.

Via Benzinga

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗

May 23, 2025

Looking for insights into the US markets one hour before the close of the markets on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 23, 2025

Via Benzinga

Let's take a look at the stocks that are in motion in today's session. ↗

May 23, 2025

Curious to know what's happening on the US markets in the middle of the day on Friday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

Gold Gains Over 1%; Ross Stores Shares Dip After Pulling Fiscal 2026 Outlook ↗

May 23, 2025

Via Benzinga

There are notable gap-ups and gap-downs in today's session. ↗

May 23, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Friday. Let's explore the market movements and identify the stocks with significant gaps.

Via Chartmill

Nasdaq Down Over 1%; Workday Shares Tumble After Q1 Results ↗

May 23, 2025

Via Benzinga

Merus Skyrockets On 'Unprecedented' Cancer Results, Slamming Bicara Therapeutics ↗

May 23, 2025

The companies are duking it out for the best treatment for head-and-neck cancer. One clearly has the edge.

Via Investor's Business Daily

Ross Stores, Deckers Outdoor, Xerox Holdings And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

May 23, 2025

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.